Latest Articles
Bindi’s searing message about battling ‘indescribable pain’ - The Nightly
Bindi’s searing message about battling ‘indescribable pain’ The Nightly
Published: April 3, 2026, 6 p.m.
LG Chem signs Korea, Thailand rights to Mochida’s endometriosis drug Dinagest - koreabiomed.com
LG Chem signs Korea, Thailand rights to Mochida’s endometriosis drug Dinagest koreabiomed.com
Published: April 3, 2026, 4:16 a.m.
Visionary arts leader John Clark, who ‘helped shape the cultural life of this city’, dies aged 93 - WAtoday
Visionary arts leader John Clark, who ‘helped shape the cultural life of this city’, dies aged 93 WAtoday
Published: April 3, 2026, 2:06 a.m.
LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical - 아시아경제
LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical 아시아경제
Published: April 2, 2026, 11:40 p.m.
Stage IV Endometriosis Patient Finds Relief Without Surgery - Endometriosis Foundation of America
Stage IV Endometriosis Patient Finds Relief Without Surgery Endometriosis Foundation of America
Published: April 2, 2026, 7:08 p.m.
Stage IV Endometriosis Patient Finds Relief Without Surgery - endofound.org
Stage IV Endometriosis Patient Finds Relief Without Surgery endofound.org
Published: April 2, 2026, 7:08 p.m.
Patients of disgraced gynaecologist to get free health reviews - The Age
Patients of disgraced gynaecologist to get free health reviews The Age
Published: April 2, 2026, 5:18 a.m.
Press conference with Assistant Minister White, Melbourne – 2 April 2026 - Australian Government Department of Health, Disability and Ageing
Press conference with Assistant Minister White, Melbourne – 2 April 2026 Australian Government Department of Health, Disability and Ageing
Published: April 2, 2026, 2:24 a.m.
Reality TV star Konrad Bien-Stephen dies aged 35 - WAtoday
Reality TV star Konrad Bien-Stephen dies aged 35 WAtoday
Published: April 2, 2026, 12:16 a.m.
Single-Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non-Pregnant, Non-Lactating Premenopausal Female Subjects Under Fasting Conditions.
Elagolix is a short-acting oral gonadotropin-releasing hormone antagonist utilized for treating endometriosis-associated pain by rapidly suppressing gonadotropins and estradiol. Although well characterized in Western populations, clinical data regarding its use …
Published: April 2, 2026, midnight
Link copied to clipboard!